EUVIMEDOpdag EUVIMED
Übersichtsarbeit

Garlic‐derived compounds: Epigenetic modulators and their antitumor effects

Huan Zhang, Haichao Wang, Lin Qin, Shuye Lin iD

Phytotherapy Research · 2024-03 · 38 (3) · 1329-1344

DOI: 10.1002/ptr.8108 ↗

At a glance

Übersichtsarbeit in Phytotherapy Research, published online on 2024-01-09. Written by Huan Zhang and 3 co-authors. Institution: Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, Chin…. Major MEDLINE topics: Garlic, Neoplasms, Allyl Compounds, Biological Products. Cited 16 times so far (Crossref); 120 references. Funded by: National Natural Science Foundation of China, Beijing Municipal Administration of Hospitals Incubating Program, R&D Program of Beijing Municipal Education Commission.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cancer is a highly heterogeneous disease that poses a serious threat to human health worldwide. Despite significant advances in the diagnosis and treatment of cancer, the prognosis and survival rate of cancer remain poor due to late diagnosis, drug resistance, and adverse reactions. Therefore, it is very necessary to study the development mechanism of cancer and formulate effective therapeutic interventions. As widely available bioactive substances, natural products have shown obvious anticancer potential, especially by targeting abnormal epigenetic changes. The main active part of garlic is organic sulfur compounds, of which diallyl trisulfide (DATS) content is the highest, accounting for more than 40% of the total composition. The garlic‐derived compounds have been recognized as an antioxidant for cancer prevention and treatment. However, the molecular mechanism of the antitumor effect of garlic‐derived compounds remains unclear. Recent studies have identified garlic‐derived compound DATS that plays critical roles in enhancing CpG demethylation or promoting histone acetylation as an epigenetic inhibitor. Here, we review the therapeutic progress of garlic‐derived compounds against cancer through epigenetic pathways.

Subjects

MeSH terms (MEDLINE)

GarlicNeoplasmsAllyl CompoundsBiological ProductsHumansAntioxidantsApoptosisSulfides

Author keywords

cancer therapydiallyl trisulfideepigenetic regulationgarlic-derived compoundsnatural products

Substances

Antioxidantsdiallyl trisulfideSulfidesAllyl CompoundsBiological Products

Authors and institutions

  • Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
  • Institute of Resources and Environment, Beijing Academy of Science and Technology, Beijing, China.
  • Department of Endoscopic Diagnosis and Treatment, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.

ORCID profiles: Shuye Lin

Funding

  • National Natural Science Foundation of China
  • Beijing Municipal Administration of Hospitals Incubating Program
  • R&D Program of Beijing Municipal Education Commission
  • Beijing Hospitals Authority Youth Programme

Cite

APA

Zhang, H., Wang, H., Qin, L., & Lin, S. (2024). Garlic‐derived compounds: Epigenetic modulators and their antitumor effects. Phytotherapy Research, 38(3), 1329-1344. https://doi.org/10.1002/ptr.8108

Vancouver

Zhang H, Wang H, Qin L, Lin S. Garlic‐derived compounds: Epigenetic modulators and their antitumor effects. Phytotherapy Research. 2024;38(3):1329-1344. doi:10.1002/ptr.8108

BibTeX
@article{Zhang2024,
  author = {Zhang, Huan and Wang, Haichao and Qin, Lin and Lin, Shuye},
  title = {Garlic‐derived compounds: Epigenetic modulators and their antitumor effects},
  journal = {Phytotherapy Research},
  year = {2024},
  volume = {38},
  number = {3},
  pages = {1329--1344},
  doi = {10.1002/ptr.8108}
}
Start for free →